![]() Reata Pharmaceuticals Reata Pharmaceuticals is a biopharmaceutical company that develops therapeutics for patients with serious or life-threatening diseases. | ![]() Apellis Pharmaceuticals Apellis Pharmaceuticals is a biopharmaceutical company focused on the development of therapeutic compounds. | ![]() Alnylam Pharmaceuticals Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. | ![]() Ionis Pharmaceuticals Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics. | ![]() Kadmon Kadmon Corporation is a biopharmaceutical company offering products and services for the treatment and management of hepatitis C. | |
Founding Date | Founding Date 2002 | Founding Date 2009 | Founding Date 2002 | Founding Date 1989 | Founding Date 2010 |
Type | Type Public | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Plano, US HQ Irving, US Plano, US | Locations Waltham, US HQ München, DE Zug, CH San Francisco, US Watertown, US | Locations Carlsbad, US HQ | Locations New York, US HQ Cambridge, US South Brunswick Township, US Warrendale, US | |
Employees | Employees 22079% increase | Employees 47627% increase | Employees 1,32324% increase | Employees 7577% decrease | Employees 1151% decrease |
Valuation ($) | Valuation ($) 1.4 b | Valuation ($) 4.9 b | Valuation ($) 27.7 b | Valuation ($) 5.6 b | Valuation ($) N/A |
Twitter followers | Twitter followers 1.3 k | Twitter followers 1.3 k | Twitter followers 16 k | Twitter followers 4.3 k | Twitter followers N/A |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 6 | Number of tweets (last 30 days) 7 | Number of tweets (last 30 days) 27 | Number of tweets (last 30 days) 8 | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 2.3 | Average likes per tweet (last 30 days) 3.9 | Average likes per tweet (last 30 days) 9.1 | Average likes per tweet (last 30 days) 6.4 | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 85.71% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A |
Alexa Website Rank | Alexa Website Rank 267230 | Alexa Website Rank 184577 | Alexa Website Rank 376993 | Alexa Website Rank 333062 | Alexa Website Rank N/A |
Employee Rating | Employee Rating 3.6 | Employee Rating 3.8 | Employee Rating 4.2 | Employee Rating 3.6 | Employee Rating 2.8 |
Financial | |||||
Revenue (est.) | Revenue (est.) $11.5m (FY, 2021) | Revenue (est.) $66.6m (FY, 2021) | Revenue (est.) $844.3m (FY, 2021) | Revenue (est.) $810.5m (FY, 2021) | Revenue (est.) $8.3m (FY, 2020) |
Cost of goods | Cost of goods N/A | Cost of goods $200k (FY, 2021) | Cost of goods $115m (FY, 2021) | Cost of goods $10.8m (FY, 2021) | Cost of goods N/A |
Net income | Net income ($297.4m) (FY, 2021) | Net income ($746.4m) (FY, 2021) | Net income ($852.8m) (FY, 2021) | Net income ($28.6m) (FY, 2021) | Net income ($108.9m) (FY, 2020) |
Operating ⚠ | |||||
Phase I Trials Products | Phase I Trials Products 2 (FY, 2016) | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products 6 (FY, 2020) | Phase I Trials Products N/A |
Phase II Trials Products | Phase II Trials Products 4 (FY, 2016) | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products 24 (FY, 2020) | Phase II Trials Products N/A |
Phase III Trials Products | Phase III Trials Products 1 (FY, 2016) | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 6 (FY, 2020) | Phase III Trials Products N/A |
Funding | |||||
Total funding raised | Total funding raised $ 468.9m | Total funding raised $ 88m | Total funding raised $ 1.5b | Total funding raised N/A | Total funding raised $ 21.3m |
Apellis Pharmaceuticals is a biopharmaceutical company focused on the development of therapeutic compounds.
View companyAlnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.
View companyIonis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.
View companyKadmon Corporation is a biopharmaceutical company offering products and services for the treatment and management of hepatitis C.
View company